clinical chemistry analyzer

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Bio & Pharma President of Latvia visits S.Korea's Daan Cancer Lab

Daan Cancer Laboratory under Severance Hospital said on Thursday it signed a memorandum of understanding (MOU) with the Latvian government to streng...

Korean startups Mediaiplus aims to be the Amazon of clinical trials

Mediaiplus Inc., South Korea’s only provider of data analytics and contract research organization (CRO) matching services for clinical trials,...

Tech, Media & Telecom LG Elec to advance in-cabin sensing solution

LG Electronics Inc. said on Monday it's advancing its in-cabin sensing solution which detects and analyzes the interior of vehicles to prevent acc...

Artificial intelligence KT to develop AI tech to filter spam messages

South Korea's KT Corp. said on Tuesday it will work with the Korea Internet & Security Agency (KISA) to launch an artificial intelligence (AI)...

Bio & Pharma Celltrion gets FDA nod for Keytruda copy's phase 3 clinical trials

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...

Beauty & Cosmetics Kolmar Korea develops AI tech for diagnosing alopecia

Kolmar Korea, a supplier to global cosmetics brands such as Estee Lauder, announced on Tuesday that it developed artificial intelligence (AI) techno...

Tech, Media & Telecom LG Uplus analyzes ad performance with GenAI

South Korea's LG Uplus Corp. announced on Monday that it has introduced generative AI technology to its integrated advertising platform U+AD, adding...

Carbon neutrality POSCO Future M completes carbon footprint verification

POSCO Future M Co., South Korea’s anode materials producer, has completed the international standard verification for the carbon footprint of ...

Bio & Pharma Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman

WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...

Bio & Pharma Global quest to find modern elixirs enters new chapter

NEW YORK/ BOSTON – Longevity has long been the dream of humankind. China’s first emperor Qin Shi Huang was obsessed with finding magic e...

Bio & Pharma SK C&C wins Korea’s nod for brain infarct diagnosis AI solution

SK Inc C&C (SK C&C), the information technology service unit of South Korea’s SK Group, said on Thursday it has secured medical device...

Tech, Media & Telecom SK Telecom to enter Australian pet clinics market in H1

South Korea’s SK Telecom Co. announced on Tuesday that it has signed a commercial contract with ATX Medical Solutions, Australia's largest m...

Bio & Pharma Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar

South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...

Robotics KIST develops wearable robot for hiking assistance

The Korea Institute of Science and Technology (KIST) announced on Thursday that it has developed a lightweight wearable robot called Moonwalk Omni, ...

Bio & Pharma LG Chem out-licenses obesity drug candidate to US firm

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

Tech, Media & Telecom SK Telecom, Naver, AfreecaTV to introduce AI in sportscasting

SK Telecom Co., Naver Corp., and AfreecaTV have joined forces to introduce artificial intelligence (AI) technology in the sports broadcasting field....

Bio & Pharma MedPacto gets FDA OK for colorectal cancer drug clinical trial

South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...

Bio & Pharma CGBio gets FDA approval for Novosis Putty

South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...

Upcoming IPOs Peter Thiel-backed D&D Pharmatech gets preliminary nod for IPO

South Korean clinical-stage biotech D&D Pharmatech Inc. has won approval from the Korea Exchange’s preliminary review for listing on the j...

Advertising & Marketing HS Ad, Coupang to co-work for retail media advertising

South Korea’s HS Ad Inc. announced on Thursday that it will collaborate with the domestic e-commerce giant Coupang for data-based digital mark...

Electronics LG Elec launches new medical monitor

LG Electronics Inc. unveiled a new medical monitor on Wednesday. This monitor boasts high brightness suitable for both clinical and diagnostic purpo...

Bio & Pharma HK inno.N reveals differentiated clinical results for K-CAB

South Korean bio-health company HK inno.N has been expanding its market by steadily announcing differentiated clinical results for its gastroesophag...

Bio & Pharma SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

Bio & Pharma Celltrion applies for approval in Europe for eye treatment biosimilar

South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...

Retail Coupang opens its second logistics center in Taiwan

Coupang Inc., South Korea’s leading e-commerce platform, has opened its second fulfillment center in Taiwan and plans to open a third one ther...

Tech, Media & Telecom Naver launches AI-based hotel recommendations service

South Korea’s web portal giant Naver Corp. has launched a beta service for For You, which recommends hotels using artificial intelligence (A...

Bio & Pharma NKMax's US subsidiary listed on Nasdaq

South Korean natural killer (NK) cell drugmaker NKMax Co. on Wednesday said its US subsidiary NKGen Biotech on Monday was listed on the Nasdaq Globa...

Artificial intelligence KT, BI Matrix to develop natural language processing AI

South Korea's KT Corp. is partnering with the intelligent solutions specialist company BI Matrix to develop technology that uses artificial intell...

Electronics Samsung, UMich to research on Galaxy Watch’s fitness feature

Samsung Electronics Co. announced on Wednesday that it is conducting research in collaboration with the University of Michigan to enhance fitness fe...